Antimicrobial β-Peptides and α-Peptoids

Chemical Biology and Drug Design

Volumn 77, Issue 2, 2011, Pages 107-116

  Godballe, Troels ^a   Nilsson, Line L ^a   Petersen, Pernille D ^a   Jenssen, Håvard ^a  

^a ROSKILDE UNIVERSITY   (Denmark)

Author keywords

peptoids; peptide; Antibiotic resistance; Antimicrobial peptides; Drug design; Peptidomimetics

Indexed keywords

ALPHA AMINO ACID; ANTIMICROBIAL ALPHA PEPTOID; ANTIMICROBIAL BETA PEPTIDE; BACTERIAL PROTEIN; BETA AMINO ACID; CERAGENIN; CERASHIELD; DAPTOMYCIN; LTX 109; LYTIXAR; OMIGANAN; PEPTIDOMIMETIC AGENT; PMX 30036; POLYMYXIN; POLYPEPTIDE ANTIBIOTIC AGENT; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; BACTERIAL SKIN DISEASE; DRUG DESIGN; DRUG STABILITY; DRUG STRUCTURE; HEMOLYSIS; MOLECULAR MIMICRY; PHASE 2 CLINICAL TRIAL (TOPIC); PHASE 3 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN DEGRADATION; PROTEIN STRUCTURE; REVIEW;

ANTI-INFECTIVE AGENTS; ANTIMICROBIAL CATIONIC PEPTIDES; HEMOLYSIS; PEPTIDOMIMETICS; PEPTOIDS; PROTEIN STRUCTURE, SECONDARY;

BACTERIA (MICROORGANISMS);

EID: 79251509263     PISSN: 17470277     EISSN: 17470285     Source Type: Journal    
DOI: 10.1111/j.1747-0285.2010.01067.x     Document Type: Review

References (96)

1. Goossens H., Ferech M., Stichele R.V., Elseviers M. (2005) Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet;365:579-587.
2. Wang G., Li X., Wang Z. (2009) APD2: the updated antimicrobial peptide database and its application in peptide design. Nucleic Acids Res;37:D933-D937.
3. Ganz T. (2003) Defensins: antimicrobial peptides of innate immunity. Nat Rev Immunol;3:710-720.
4. Jenssen H., Hamill P., Hancock R.E.W. (2006) Peptide antimicrobial agents. Clin Microbiol Rev;19:491-511.
5. Steiner H., Hultmark D., Engstrom A., Bennich H., Boman H.G. (2009) Sequence and specificity of two antibacterial proteins involved in insect immunity (Reprinted from Nature, vol 292, pg 246-248, 1981). J Immunol;182:6635-6637.
6. Dathe M., Wieprecht T. (1999) Structural features of helical antimicrobial peptides: their potential to modulate activity on model membranes and biological cells. Biochim Biophys Acta;1462:71-87.
7. Chen Y., Ho D.M., Gottlieb C.R., Kahne D., Bruck M.A. (1992) Facial amphiphiles. J Am Chem Soc;114:7319-7320.
8. Giangaspero A., Sandri L., Tossi A. (2001) Amphipathic alpha helical antimicrobial peptides - a systematic study of the effects of structural and physical properties on biological activity. Eur J Biochem;268:5589-5600.
9. Ryge T.S., Frimodt-Moller N., Hansen P.R. (2008) Antimicrobial activities of twenty lysine-peptoid hybrids against clinically relevant bacteria and fungi. Chemotherapy;54:152-156.
10. Hancock R.E.W., Sahl H.G. (2006) Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies. Nat Biotechnol;24:1551-1557.
11. Jenssen H. (2009) Clinical development of peptide antibiotics. PharmaChem;10:22-26.
12. Jenssen H., Hancock R.E.W. (2010) Therapeutic potential of HDPs as immunomodulatory agents. Methods Mol Biol;618:329-347.
13. Latham P.W. (1999) Therapeutic peptides revisited. Nat Biotechnol;17:755-757.
14. Boman H.G. (2003) Antibacterial peptides: basic facts and emerging concepts. J Intern Med;254:197-215.
15. Rotem S., Mor A. (2009) Antimicrobial peptide mimics for improved therapeutic properties. Biochim Biophys Acta;1788:1582-1592.
16. Lee K.H., Oh J.E. (2000) Design and synthesis of novel antimicrobial pseudopeptides with selective membrane-perturbation activity. Bioorg Med Chem;8:833-839.
17. Seebach D., Beck A.K., Bierbaum D.J. (2004) The world of beta- and gamma-peptides comprised of homologated proteinogenic amino acids and other components. Chem Biodivers;1:1111-1239.
18. Porter E.A., Wang X., Lee H.S., Weisblum B., Gellman S.H. (2000) Non-haemolytic beta-amino-acid oligomers. Nature;404:565. Erratum: 2000, 405(6784):298.
19. Zasloff M. (1987) Magainins, a class of antimicrobial peptides from Xenopus skin: isolation, characterization of two active forms, and partial cDNA sequence of a precursor. Proc Natl Acad Sci U S A;84:5449-5453.
20. Hamuro Y., Schneider J.P., DeGrado W.F. (1999) De novo design of antibacterial beta-peptides. J Am Chem Soc;121:12200-12201.
21. Bode K.A., Applequist J. (1997) Helix bundles and coiled coils in alpha-spectrin and tropomyosin: a theoretical CD study. Biopolymers;42:855-860.
22. Seebach D., Ciceri P.E., Overhand M., Jaun B., Rigo D., Oberer L., Hommel U., Amstutz R., Widmer H. (1996) Probing the helical secondary structure of short-chain beta-peptides. Helv Chim Acta;79:2043-2066.
23. Appella D.H., Christianson L.A., Karle I.L., Powell D.R., Gellman S.H. (1996) Beta-peptide foldamers: Robust Helix formation in a new family of beta-amino acid oligomers. J Am Chem Soc;118:13071-13072.
24. Appella D.H., Christianson L.A., Klein D.A., Powell D.R., Huang X., Barchi J.J. Jr, Gellman S.H. (1997) Residue-based control of helix shape in beta-peptide oligomers. Nature;387:381-384.
25. Appella D.H., Barchi J.J. Jr, Durell S.R., Gellman S.H. (1999) Formation of short, stable helices in aqueous solution by β-amino acid hexamers. J Am Chem Soc;121:2309-2310.
26. Seebach D., Gademann K., Schreiber J.V., Matthews J.L., Hintermann T., Jaun B., Oberer L., Hommel U., Widmer H. (1997) 'Mixed' beta-peptides: a unique helical secondary structure in solution. Helv Chim Acta;80:2033-2038.
27. Vasudev P.G., Chatterjee S., Ananda K., Shamala N., Balaram P. (2008) Hybrid alphagamma polypeptides: structural characterization of a C12/C10 helix with alternating hydrogen-bond polarity. Angew Chem Int Ed Engl;47:6430-6432.
28. Chung Y.J., Christianson L.A., Stanger H.E., Powell D.R., Gellman S.H. (1998) A beta-peptide reverse turn that promotes hairpin formation. J Am Chem Soc;120:10555-10556.
29. Krauthauser S., Christianson L.A., Powell D.R., Gellman S.H. (1997) Antiparallel sheet formation in beta-peptide foldamers: effects of beta-amino acid substitution on conformational preference. J Am Chem Soc;119:11719-11720.
30. Chung Y.J., Huck B.R., Christianson L.A., Stanger H.E., Krauthauser S., Powell D.R., Gellman S.H. (2000) Stereochemical control of hairpin formation in beta-peptides containing dinipecotic acid reverse turn segments. J Am Chem Soc;122:3995-4004.
31. Farmer P.S., Ariens E.J. (1982) Speculations on the design of non-peptidic peptidomimetics. Trends Pharmacol Sci;3:362-365.
32. Zuckermann R.N., Kerr J.M., Kent S.B.H., Moos W.H. (1992) Efficient method for the preparation of peptoids [oligo(N-substituted glycines)] by submonomer solid-phase synthesis. J Am Chem Soc;114:10646-10647.
33. Miller S.M., Simon R.J., Ng S., Zuckermann R.N., Kerr J.M., Moos W.H. (1994) Proteolytic studies of homologous peptide and N-substituted glycine peptoid oligomers. Bioorg Med Chem Lett;4:2657-2662.
34. Zhu W.L., Song Y.M., Park Y., Park K.H., Yang S.T., Kim J.I., Park I.S., Hahm K.S., Shin S.Y. (2007) Substitution of the leucine zipper sequence in melittin with peptoid residues affects self-association, cell selectivity, and mode of action. Biochim Biophys Acta;1768:1506-1517.
35. Patch J.A., Barron A.E. (2003) Helical peptoid mimics of magainin-2 amide. J Am Chem Soc;125:12092-12093.
36. Haug B.E., Stensen W., Kalaaji M., Rekdal O., Svendsen J.S. (2008) Synthetic antimicrobial peptidomimetics with therapeutic potential. J Med Chem;51:4306-4314.
37. Boman H.G. (1995) Peptide antibiotics and their role in innate immunity. Annu Rev Immunol;13:61-92.
38. Brogden K.A. (2005) Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria? Nat Rev Microbiol;3:238-250.
39. Hancock R.E.W., Rozek A. (2002) Role of membranes in the activities of antimicrobial cationic peptides. FEMS Microbiol Lett;206:143-149.
40. Salditt T., Li C.H., Spaar A. (2006) Structure of antimicrobial peptides and lipid membranes probed by interface-sensitive X-ray scattering. Biochim Biophys Acta;1758:1483-1498.
41. Scott M.G., Gold M.R., Hancock R.E.W. (1999) Interaction of cationic peptides with lipoteichoic acid and gram-positive bacteria. Infect Immun;67:6445-6453.
42. Cardillo G., Tomasini C. (1996) Asymmetric synthesis of beta-amino acids and alpha-substituted beta-amino acids. Chem Soc Rev;25:117-128.
43. Patch J.A., Barron A.E. (2002) Mimicry of bioactive peptides via non-natural, sequence-specific peptidomimetic oligomers. Curr Opin Chem Biol;6:872-877.
44. Schmitt M.A., Weisblum B., Gellman S.H. (2004) Unexpected relationships between structure and function in alpha, beta-peptides: antimicrobial foldamers with heterogeneous backbones. J Am Chem Soc;126:6848-6849.
45. Martinek T.A., Fulop F. (2003) Side-chain control of beta-peptide secondary structures. Eur J Biochem;270:3657-3666.
46. Hart S.A., Bahadoor A.B., Matthews E.E., Qiu X.J., Schepartz A. (2003) Helix macrodipole control of beta 3 peptide 14-helix stability in water. J Am Chem Soc;125:4022-4023.
47. Baldauf C., Pisabarro M.T. (2008) Stable hairpins with beta-peptides: route to tackle protein-protein interactions. J Phys Chem B;112:7581-7591.
48. Raguse T.L., Porter E.A., Weisblum B., Gellman S.H. (2002) Structure-activity studies of 14-helical antimicrobial beta-peptides: probing the relationship between conformational stability and antimicrobial potency. J Am Chem Soc;124:12774-12785.
49. Schmitt M.A., Weisblum B., Gellman S.H. (2007) Interplay among folding, sequence, and lipophilicity in the antibacterial and hemolytic activities of alpha/beta-peptides. J Am Chem Soc;129:417-428.
50. Mohle K., Gunther R., Thormann M., Sewald N., Hofmann H.J. (1999) Basic conformers in beta-peptides. Biopolymers;50:167-184.
51. Cheng R.P., Gellman S.H., DeGrado W.F. (2001) beta-Peptides: from structure to function. Chem Rev;101:3219-3232.
52. Liu D.H., DeGrado W.F. (2001) De novo design, synthesis, and characterization of antimicrobial beta-peptides. J Am Chem Soc;123:7553-7559.
53. Park N.G., Lee S., Oishi O., Aoyagi H., Iwanaga S., Yamashita S., Ohno M. (1992) Conformation of tachyplesin I from Tachypleus tridentatus when interacting with lipid matrices. Biochemistry;31:12241-12247.
54. Turner J., Cho Y., Dinh N.N., Waring A.J., Lehrer R.I. (1998) Activities of LL-37, a cathelin-associated antimicrobial peptide of human neutrophils. Antimicrob Agents Chemother;42:2206-2214.
55. Rozek A., Friedrich C.L., Hancock R.E.W. (2000) Structure of the bovine antimicrobial peptide indolicidin bound to dodecylphosphocholine and sodium dodecyl sulfate micelles. Biochemistry;39:15765-15774.
56. Appella D.H., Christianson L.A., Klein D.A., Richards M.R., Powell D.R., Gellman S.H. (1999) Synthesis and structural characterization of helix-forming beta-peptides: trans-2-aminocyclopentanecarboxylic acid oligomers. J Am Chem Soc;121:7574-7581.
57. Porter E.A., Weisblum B., Gellman S.H. (2002) Mimicry of host-defense peptides by unnatural oligomers: antimicrobial beta-peptides. J Am Chem Soc;124:7324-7330.
58. Bolintineanu D., Hazrati E., Davis H.T., Lehrer R.I., Kaznessis Y.N. (2010) Antimicrobial mechanism of pore-forming protegrin peptides: 100 pores to kill E. coli. Peptides;31:1-8.
59. Grant E. Jr, Beeler T.J., Taylor K.M., Gable K., Roseman M.A. (1992) Mechanism of magainin 2a induced permeabilization of phospholipid vesicles. Biochemistry;31:9912-9918.
60. den Hertog A.L., van Marle J., Veerman E.C., Valentijn-Benz M., Nazmi K., Kalay H., Grun C.H., Van't Hof W., Bolscher J.G., Nieuw Amerongen A.V. (2006) The human cathelicidin peptide LL-37 and truncated variants induce segregation of lipids and proteins in the plasma membrane of Candida albicans. Biol Chem;387:1495-1502.
61. Schibli D.J., Epand R.F., Vogel H.J., Epand R.M. (2002) Tryptophan-rich antimicrobial peptides: comparative properties and membrane interactions. Biochem Cell Biol;80:667-677.
62. Oren Z., Shai Y. (1997) Selective lysis of bacteria but not mammalian cells by diastereomers of melittin: structure-function study. Biochemistry;36:1826-1835.
63. Wiegand H., Wirz B., Schweitzer A., Gross G., Perez M.I.R., Andres H., Kimmerlin T., Rueping M., Seebach D. (2004) Pharmacokinetic investigation of a C-14-labelled beta(3)/alpha tetrapeptide in rats. Chem Biodivers;1:1812-1828.
64. Bland J.M., De Lucca A.J., Jacks T.J., Vigo C.B. (2001) All-D-cecropin B: synthesis, conformation, lipopolysaccharide binding, and antibacterial activity. Mol Cell Biochem;218:105-111.
65. Arvidsson P.I., Frackenpohl J., Ryder N.S., Liechty B., Petersen F., Zimmermann H., Camenisch G.P., Woessner R., Seebach D. (2001) On the antimicrobial and hemolytic activities of amphiphilic beta-peptides. Chembiochem;2:771-773.
66. Arvidsson P.I., Ryder N.S., Weiss H.M., Gross G., Kretz O., Woessner R., Seebach D. (2003) Antibiotic and hemolytic activity of a beta(2)/beta(3) peptide capable of folding into a 12/10-helical secondary structure. Chembiochem;4:1345-1347.
67. Strom M.B., Haug B.E., Skar M.L., Stensen W., Stiberg T., Svendsen J.S. (2003) The pharmacophore of short cationic antibacterial peptides. J Med Chem;46:1567-1570.
68. Hansen T., Alst T., Havelkova M., Strom M.B. (2010) Antimicrobial activity of small beta-peptidomimetics based on the pharmacophore model of short cationic antimicrobial peptides. J Med Chem;53:595-606.
69. Nandel F.S., Saini A. (2007) Conformational study of short peptoid models for future applications as potent antimicrobial compounds. Macromol Theory Simul;16:295-303.
70. Fowler S.A., Blackwell H.E. (2009) Structure-function relationships in peptoids: recent advances toward deciphering the structural requirements for biological function. Org Biomol Chem;7:1508-1524.
71. Masip I., Perez-Paya E., Messeguer A. (2005) Peptoids as source of compounds eliciting antibacterial activity. Comb Chem High Throughput Screen;8:235-239.
72. Chongsiriwatana N.P., Patch J.A., Czyzewski A.M., Dohm M.T., Ivankin A., Gidalevitz D., Zuckermann R.N., Barron A.E. (2008) Peptoids that mimic the structure, function, and mechanism of helical antimicrobial peptides. Proc Natl Acad Sci U S A;105:2794-2799.
73. Wu C.W., Sanborn T.J., Huang K., Zuckermann R.N., Barron A.E. (2001) Peptoid oligomers with alpha-chiral, aromatic side chains: sequence requirements for the formation of stable peptoid helices. J Am Chem Soc;123:6778-6784.
74. Burkoth T.S., Beausoleil E., Kaur S., Tang D.Z., Cohen F.E., Zuckermann R.N. (2002) Toward the synthesis of artificial proteins: the discovery of an amphiphilic helical peptoid assembly. Chem Biol;9:647-654.
75. Gorske B.C., Stringer J.R., Bastian B.L., Fowler S.A., Blackwell H.E. (2009) New strategies for the design of folded peptoids revealed by a survey of noncovalent interactions in model systems. J Am Chem Soc;131:16555-16567.
76. Armand P., Kirshenbaum K., Falicov A., Dunbrack R.L., Dill K.A., Zuckermann R.N., Cohen F.E. (1997) Chiral N-substituted glycines can form stable helical conformations. Fold Des;2:369-375.
77. Asthana N., Yadav S.P., Ghosh J.K. (2004) Dissection of antibacterial and toxic activity of melittin - a leucine zipper motif plays a crucial role in determining its hemolytic activity but not antibacterial activity. J Biol Chem;279:55042-55050.
78. Ryge T.S., Hansen P.R. (2005) Novel lysine-peptoid hybrids with antibacterial properties. J Pept Sci;11:727-734.
79. Ng S., Goodson B., Ehrhardt A., Moos W.H., Siani M., Winter J. (1999) Combinatorial discovery process yields antimicrobial peptoids. Bioorg Med Chem;7:1781-1785.
80. Goodson B., Ehrhardt A., Ng S., Nuss J., Johnson K., Giedlin M., Yamamoto R., Moos W.H., Krebber A., Ladner M., Giacona M.B., Vitt C., Winter J. (1999) Characterization of novel antimicrobial peptoids. Antimicrob Agents Chemother;43:1429-1434.
81. Humet M., Carbonell T., Masip I., Sanchez-Baeza F., Mora P., Canton E., Gobernado M., Abad C., Perez-Paya E., Messaguer A. (2003) A positional scanning combinatorial library of peptoids as a source of biological active molecules: identification of antimicrobials. J Comb Chem;5:597-605.
82. Wiegand I., Hilpert K., Hancock R.E.W. (2008) Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances. Nat Protoc;3:163-175.
83. Fux C.A., Stoodley P., Hall-Stoodley L., Costerton J.W. (2003) Bacterial biofilms: a diagnostic and therapeutic challenge. Expert Rev Anti Infect Ther;1:667-683.
84. Parvizi J., Wickstrom E., Zeiger A.R., Adams C.S., Shapiro I.M., Purtill J.J., Sharkey P.F., Hozack W.J., Rothman R.H., Hickok N.J. (2004) Frank Stinchfield Award. Titanium surface with biologic activity against infection. Clin Orthop Relat Res;33-38.
85. Gabriel M., Nazmi K., Veerman E.C., Nieuw Amerongen A.V., Zentner A. (2006) Preparation of LL-37-grafted titanium surfaces with bactericidal activity. Bioconjug Chem;17:548-550.
86. Aumsuwan N., Heinhorst S., Urban M.W. (2007) Antibacterial surfaces on expanded polytetrafluoroethylene; penicillin attachment. Biomacromolecules;8:713-718.
87. Hilpert K., Elliott M., Jenssen H., Kindrachuk J., Fjell C.D., Korner J., Winkler D.F., Weaver L.L., Henklein P., Ulrich A.S., Chiang S.H., Farmer S.W., Pante N., Volkmer R., Hancock R.E.W. (2009) Screening and characterization of surface-tethered cationic peptides for antimicrobial activity. Chem Biol;16:58-69.
88. Statz A.R., Park J.P., Chongsiriwatana N.P., Barron A.E., Messersmith P.B. (2008) Surface-immobilised antimicrobial peptoids. Biofouling;24:439-448.
89. Giuliani A., Pirri G., Nicoletto S.F. (2007) Antimicrobial peptides: an overview of a promising class of therapeutics. Cent Eur J Biol;2:1-33.
90. Rubinchik E., Dugourd D., Algara T., Pasetka C., Friedland H.D. (2009) Antimicrobial and antifungal activities of a novel cationic antimicrobial peptide, omiganan, in experimental skin colonisation models. Int J Antimicrob Agents;34:457-461.
91. Lai X.Z., Feng Y., Pollard J., Chin J.N., Rybak M.J., Bucki R., Epand R.F., Epand R.M., Savage P.B. (2008) Ceragenins: cholic acid-based mimics of antimicrobial peptides. Acc Chem Res;41:1233-1240.
92. Chin J.N., Rybak M.J., Cheung C.M., Savage P.B. (2007) Antimicrobial activities of ceragenins against clinical isolates of resistant Staphylococcus aureus. Antimicrob Agents Chemother;51:1268-1273.
93. Gesell J., Zasloff M., Opella S.J. (1997) Two-dimensional 1H NMR experiments show that the 23-residue magainin antibiotic peptide is an alpha-helix in dodecylphosphocholine micelles, sodium dodecylsulfate micelles, and trifluoroethanol/water solution. J Biomol NMR;9:127-135.
94. Guex N., Peitsch M.C. (1997) SWISS-MODEL and the Swiss-PdbViewer: an environment for comparative protein modeling. Electrophoresis;18:2714-2723.
95. Goodman C.M., Choi S., Shandler S., DeGrado W.F. (2007) Foldamers as versatile frameworks for the design and evolution of function. Nat Chem Biol;3:252-262.
96. Wu Y.D., Han W., Wang D.P., Gao Y., Zhao Y.L. (2008) Theoretical analysis of secondary structures of beta-peptides. Acc Chem Res;41:1418-1427.